HOT-2
HOT-2 (also known as 2,5-dimethoxy-4-ethylthioamphetamine) is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin and documented in his book, PiHKAL (Phenethylamines I Have Known And Loved).
History[edit]
HOT-2 was first synthesized and studied by Alexander Shulgin. The detailed synthesis and personal bioassay information was published in his book PiHKAL. The compound is part of a series of psychedelic phenethylamines, collectively referred to as the HOT series, which were developed by Shulgin for their psychoactive properties.
Chemistry[edit]
HOT-2 is a derivative of 2C-H, which is a primary amine of the 2C family. The chemical structure consists of a phenethylamine core, with an additional ethylthio group attached to the 4th position of the phenyl ring, and two methoxy groups attached at the 2nd and 5th positions.
Pharmacology[edit]
Like other psychedelic phenethylamines, HOT-2 is thought to act primarily as a 5-HT2A receptor agonist. This receptor is involved in the release of the neurotransmitter serotonin, which plays a role in regulating mood, appetite, sleep, and other functions. The exact mechanism of action, however, is not fully understood.
Effects[edit]
The effects of HOT-2 are similar to other psychedelic phenethylamines, and can include visual hallucinations, enhanced perception, euphoria, and altered thought patterns. The duration of effects typically lasts between 6 to 8 hours, but can vary depending on the dose and individual metabolism.
Legal Status[edit]
The legal status of HOT-2 varies by country. In the United States, it is not specifically listed as a controlled substance, but it could potentially be considered an analog of a controlled substance under the Federal Analogue Act.
See Also[edit]
-
HOT-2
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian